These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21361860)

  • 21. [Which patients with atrial fibrillation need anticoagulation?].
    Despotovic SF; Siewe S; Keta A
    Rev Med Suisse; 2010 Sep; 6(264):1816-8, 1820. PubMed ID: 20964018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug therapy in atrial fibrillation].
    Schuchert A
    Herzschrittmacherther Elektrophysiol; 2014 Mar; 25(1):1-2. PubMed ID: 24525719
    [No Abstract]   [Full Text] [Related]  

  • 24. Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.
    Yan BP; Kiernan TJ; Gonzales-Cruz I; Lam YY
    Expert Rev Med Devices; 2009 Nov; 6(6):611-20. PubMed ID: 19911873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of endothelial (dys)function in atrial fibrillation.
    Krishnamoorthy S; Lim SH; Lip GY
    Ann Med; 2009; 41(8):576-90. PubMed ID: 19711210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?
    Kudenchuk PJ
    J Thromb Thrombolysis; 2015 Apr; 39(3):345-52. PubMed ID: 25648874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 28. Paroxysmal atrial fibrillation: why patients experience different symptoms from the same arrhythmia?
    Smeets JL
    Neth J Med; 2005 May; 63(5):154-5. PubMed ID: 15952482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stroke prevention in atrial fibrillation patients.
    Marinigh R; Lip GY; Lane DA
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure. The forgotten factor in previous and recent studies regarding anticoagulation in atrial fibrillation.
    Kallistratos MS; Manolis AJ; Mancia G
    Int J Cardiol; 2013 Oct; 168(4):4434-5. PubMed ID: 23890867
    [No Abstract]   [Full Text] [Related]  

  • 32. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 33. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 34. Atrial fibrillation: goals of therapy and management strategies to achieve the goals.
    Padanilam BJ; Prystowsky EN
    Cardiol Clin; 2009 Feb; 27(1):189-200, x. PubMed ID: 19111774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The endothelium and atrial fibrillation. The prothrombotic state revisited.
    Freestone B; Lip GY
    Hamostaseologie; 2008 Oct; 28(4):207-12. PubMed ID: 18836646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New approaches to atrial fibrillation management: treat the patient, not the ECG.
    Pinter A; Dorian P
    Cardiovasc Ther; 2010 Oct; 28(5):302-10. PubMed ID: 20345495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial fibrillation: food for thought in 2013.
    Alpert JS
    Am J Med; 2013 Nov; 126(11):937-8. PubMed ID: 24157284
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation: preventing thromboembolism and choosing nondrug therapies.
    Chandramouli BV; Kotler MN
    Geriatrics; 1998 Jul; 53(7):53-60. PubMed ID: 9672497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?
    Pamukcu B; Lane DA; Lip GY
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1703-10. PubMed ID: 21108552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.